KUAISHOU-W
01024
XIAOMI-W
01810
JD HEALTH
06618
4
BILIBILI-W
09626
5
ALI HEALTH
00241
(Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | (Q6)Sep 30, 2020 | (FY)Mar 31, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 11.68%-902.73M | ---- | -91.62%-1.02B | ---- | -253.81%-533.39M | ---- | 176.93%346.79M | ---- | -129.46%-450.81M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -11.98%157.19M | ---- | 3,077.49%178.59M | ---- | 61.46%-6M | ---- | 74.05%-15.57M | ---- | -80.68%-59.97M |
Dividend (income)- adjustment | ---- | 0.00%-7.37M | ---- | 1.38%-7.37M | ---- | 0.00%-7.47M | ---- | -104.80%-7.47M | ---- | 25.93%-3.65M |
Impairment and provisions: | ---- | 50.81%299.29M | ---- | 1,983.68%198.45M | ---- | 961.76%9.52M | ---- | 112.72%897K | ---- | 36.19%-7.05M |
-Impairment of property, plant and equipment (reversal) | ---- | -38.52%32.48M | ---- | --52.82M | ---- | ---- | ---- | ---- | ---- | ---- |
-Impairmen of inventory (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 64.62%-2.3M | ---- | ---6.5M |
-Impairment of trade receivables (reversal) | ---- | -48.78%4.5M | ---- | 3,237.86%8.79M | ---- | -108.76%-280K | ---- | 41.27%3.2M | ---- | 260.27%2.26M |
-Other impairments and provisions | ---- | 91.69%262.32M | ---- | 1,295.80%136.84M | ---- | --9.8M | ---- | ---- | ---- | 68.31%-2.81M |
Revaluation surplus: | ---- | -38.66%326.75M | ---- | -68.53%532.73M | ---- | 691.76%1.69B | ---- | -10.99%213.77M | ---- | 121.55%240.16M |
-Fair value of investment properties (increase) | ---- | -38.66%326.75M | ---- | 1,576.22%532.73M | ---- | -108.32%-36.09M | ---- | 80.67%433.9M | ---- | 121.55%240.16M |
-Other fair value changes | ---- | ---- | ---- | ---- | ---- | 885.26%1.73B | ---- | ---220.13M | ---- | ---- |
Asset sale loss (gain): | ---- | -94.99%587K | ---- | 100.99%11.71M | ---- | -9,664.87%-1.18B | ---- | 163.71%12.32M | ---- | 101.01%4.67M |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | 101.12%13.17M | ---- | -11,568.37%-1.18B | ---- | --10.28M | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | 93.87%-89K | ---- | -848.45%-1.45M | ---- | -73.35%194K | ---- | -71.41%728K | ---- | 6,628.21%2.55M |
-Loss (gain) from selling other assets | ---- | --676K | ---- | ---- | ---- | -94.30%75K | ---- | -38.18%1.32M | ---- | --2.13M |
Depreciation and amortization: | ---- | 10.47%41.79M | ---- | -60.06%37.83M | ---- | -7.30%94.72M | ---- | -9.59%102.17M | ---- | 28.51%113.02M |
Special items | ---- | ---20.91M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Operating profit before the change of operating capital | ---- | -50.22%-105.4M | ---- | -198.47%-70.17M | ---- | -89.09%71.25M | ---- | 499.02%652.92M | ---- | -2,284.91%-163.63M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 183.57%1.02M | ---- | -163.12%-1.22M | ---- | 58.68%1.93M | ---- | -97.11%1.22M | ---- | 2,286.82%42.01M |
Developing property (increase)decrease | ---- | 45.04%-41.75M | ---- | -187.94%-75.95M | ---- | -90.38%86.37M | ---- | 189.84%898.04M | ---- | -159.23%-999.54M |
Accounts receivable (increase)decrease | ---- | -93.00%9.16M | ---- | 2.71%130.94M | ---- | 346.69%127.48M | ---- | 20.01%-51.68M | ---- | -1,291.10%-64.61M |
Accounts payable increase (decrease) | ---- | 109.40%13.04M | ---- | -147.10%-138.69M | ---- | -126.06%-56.13M | ---- | 471.55%215.37M | ---- | -30.85%37.68M |
Advance payment increase (decrease) | ---- | -204.34%-9.16M | ---- | 182.16%8.78M | ---- | 99.31%-10.69M | ---- | -227.48%-1.54B | ---- | 256.89%1.21B |
Financial assets at fair value (increase)decrease | ---- | -99.16%3.59M | ---- | -24.07%427.81M | ---- | 172.26%563.43M | ---- | -164.29%-779.71M | ---- | -120.23%-295.02M |
Special items for working capital changes | ---- | -98.39%2.33M | ---- | 1,831.80%144.38M | ---- | 51.01%-8.34M | ---- | 45.74%-17.02M | ---- | 63.57%-31.37M |
Cash from business operations | ---- | -133.21%-136.08M | ---- | -47.14%409.8M | ---- | 224.48%775.32M | ---- | -135.13%-622.84M | ---- | -25.00%-264.89M |
Other taxs | ---- | -15.48%-6.42M | ---- | 97.02%-5.56M | ---- | 0.47%-186.69M | ---- | -2,298.93%-187.57M | ---- | 84.63%-7.82M |
Interest paid - operating | ---- | -29.52%-228.61M | ---- | -47.34%-176.51M | ---- | 17.78%-119.79M | ---- | 46.82%-145.69M | ---- | -39.07%-273.94M |
Special items of business | 15.31%-154.09M | ---- | -145.10%-181.95M | ---- | 111.50%403.45M | ---- | 140.89%190.76M | ---- | -91.42%-466.57M | ---- |
Net cash from operations | 15.31%-154.09M | -262.96%-371.11M | -145.10%-181.95M | -51.43%227.73M | 111.50%403.45M | 149.04%468.83M | 140.89%190.76M | -74.90%-956.1M | -91.42%-466.57M | -18.90%-546.65M |
Cash flow from investment activities | ||||||||||
Interest received - investment | -7.28%45.45M | 51.72%100.56M | 237.07%49.02M | 1,027.23%66.28M | 390.65%14.54M | -67.96%5.88M | -75.51%2.96M | -69.62%18.35M | -60.07%12.1M | 95.12%60.41M |
Dividend received - investment | ---- | 0.00%7.47M | ---- | -1.36%7.47M | ---- | 0.00%7.57M | ---- | 102.00%7.57M | ---- | -25.42%3.75M |
Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -91.93%23K | ---- | -61.54%285K |
Decrease in deposits (increase) | -398.19%-151.35M | -32.08%-163.76M | 200.65%50.76M | -2,561.74%-123.98M | -1,707.53%-50.43M | -1,060.41%-4.66M | ---2.79M | 5,488.89%485K | ---- | -100.46%-9K |
Sale of fixed assets | ---- | -93.05%112K | ---- | 1,913.75%1.61M | ---- | -62.79%80K | ---- | 61.65%215K | ---- | 29.13%133K |
Purchase of fixed assets | ---- | 94.84%-240K | ---- | -95.62%-4.65M | ---- | 84.14%-2.38M | ---- | -238.03%-14.99M | ---- | 76.06%-4.43M |
Sale of subsidiaries | --254.45M | ---- | ---- | -95.29%144.64M | -90.08%144.64M | 219.10%3.07B | 51.53%1.46B | --962.16M | --962.16M | ---- |
Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---9.89M |
Recovery of cash from investments | -70.78%9.88M | --33.12M | 86,566.67%33.8M | ---- | -99.93%39K | 104.79%59.8M | 241.84%59.7M | 32.73%29.2M | 592.98%17.46M | --22M |
Cash on investment | 2,230.90%161.52M | 17.71%-12.63M | 77.05%-7.58M | 41.37%-15.35M | -744.90%-33.03M | 42.90%-26.18M | 85.58%-3.91M | 65.17%-45.85M | -10.18%-27.11M | -22.41%-131.62M |
Other items in the investment business | -104.70%-315K | 74.09%-16.15M | 35.04%6.7M | -8,500.00%-62.33M | -33.17%4.96M | --742K | 3.80%7.43M | ---- | 842.12%7.15M | ---- |
Net cash from investment operations | 140.87%319.63M | -476.32%-51.51M | 64.38%132.7M | -99.56%13.69M | -94.69%80.73M | 225.03%3.11B | 56.56%1.52B | 1,711.93%957.18M | 13,301.86%971.77M | -104.92%-59.38M |
Net cash before financing | 436.11%165.54M | -275.06%-422.62M | -110.17%-49.25M | -93.26%241.42M | -71.72%484.18M | 330,456.05%3.58B | 238.90%1.71B | 100.18%1.08M | 313.62%505.2M | -181.17%-606.03M |
Cash flow from financing activities | ||||||||||
New borrowing | -38.60%65.75M | -15.14%206.15M | -78.07%107.09M | -86.77%242.94M | 6.70%488.38M | 111.69%1.84B | 23.71%457.72M | -42.88%867.67M | -71.03%369.98M | -31.38%1.52B |
Refund | -77.35%-660.2M | 56.92%-610.33M | 36.23%-372.26M | 59.94%-1.42B | 18.43%-583.72M | -288.91%-3.54B | -6.92%-715.63M | 46.35%-909.35M | 29.64%-669.28M | -33.46%-1.7B |
Dividends paid - financing | ---- | ---- | ---- | -234.85%-425.68M | ---425.68M | -226.54%-127.13M | ---- | 74.43%-38.93M | ---- | 12.73%-152.26M |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---695K | ---- | ---- | ---- | ---- |
Net cash from financing operations | -117.55%-602.18M | 73.91%-422.79M | 47.96%-276.8M | 12.34%-1.62B | -98.68%-531.85M | -1,729.94%-1.85B | 13.51%-267.69M | 71.18%-101.01M | -198.09%-309.51M | -145.59%-350.56M |
Effect of rate | 568.29%11.55M | 213.21%2.24M | -9.75%-2.47M | -115.66%-1.98M | -128.05%-2.25M | 10.43%12.62M | -30.42%8.01M | 174.25%11.43M | 176.75%11.51M | -58.63%-15.39M |
Net Cash | -33.92%-436.64M | 38.70%-845.41M | -583.94%-326.05M | -179.65%-1.38B | -103.30%-47.67M | 1,832.62%1.73B | 638.14%1.44B | 89.55%-99.93M | 147.56%195.69M | -163.12%-956.59M |
Begining period cash | -30.19%1.95B | -33.09%2.79B | -33.09%2.79B | 81.87%4.17B | 81.87%4.17B | -8.86%2.29B | -8.86%2.29B | -27.85%2.52B | -27.85%2.52B | 75.90%3.49B |
Items Period | ---- | ---- | ---- | ---- | ---- | 200.00%134.65M | --134.65M | ---134.65M | ---- | ---- |
Cash at the end | -38.14%1.52B | -30.19%1.95B | -40.25%2.46B | -33.09%2.79B | 6.23%4.12B | 81.87%4.17B | 42.45%3.88B | -8.86%2.29B | -23.32%2.73B | -27.85%2.52B |
Cash balance analysis | ||||||||||
Bank deposits | -459.10%-445.56M | ---- | -40.07%-79.69M | ---- | -1,137.65%-56.9M | ---- | -156.96%-4.6M | ---- | 21.19%-1.79M | ---- |
Cash and cash equivalent balance | -459.10%-445.56M | ---- | -40.07%-79.69M | ---- | -1,137.65%-56.9M | ---- | -156.96%-4.6M | ---- | 21.19%-1.79M | ---- |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.